“Israeli companies may have overlooked the UK as a trial site in the past, but now they can take advantage of streamlined access that is being offered locally by the UK Israel Tech Hub and by a new agency, NOCRI, the NIHR Organization for
“Time can often be the most expensive factor in conducting a clinical trial,” explains Iris Geffen Gloor. “NOCRI now provides rapid access to clinical investigators, patient recruitment, data gathering and the world-class UK research infrastructure.”
On November 7-8, NOCRI managers will conduct two seminars and workshops in Ramat Gan, about the new services offered by NOCRI. Nov. 7 will be devoted to Biotech/Pharma and Nov. 8 to Medical Device and Diagnostics. Each session will be followed by 1:1 meetings with selected companies.
The seminar, which is being led by NOCRI Managing Director Mark Samuels, (see feature story) is being hosted by the UK Israel Tech Hub at The British Embassy, together with UKTI.
The UK Israel Tech Hub at the British Embassy Israel (the “Hub”) was set up a year ago to promote a UK – Israel partnership in technology.
“The Israeli tech scene has had a strong synergetic relationship with the US for many years. This model can be viewed as a benchmark for win/win relations between two economies, which can be replicated and adapted to the UK market,” says Iris Geffen Gloor.
She points out that the UK offers many advantages for collaborating and the locally-based Hub staff are tailoring the unique strengths of companies in each country to match each other.
To participate contact Iris Geffen Gloor, Biomed Manager, UK Israel Tech Hub@ The British Embassy in Israel iris@UKIsraelHub.com